GOLDENWELL BIOTECH, INC. (GWLL) Revenue 2019–2025
GOLDENWELL BIOTECH, INC. (GWLL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$55FY2025 · since FY2019: $0 → $55
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55 | -60.4% |
| FY2024 | $139 | -94.1% |
| FY2023 | $2,340 | -95.1% |
| FY2022 | $47,800 | +199.4% |
| FY2021 | $15,967 | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL Net incomeGWLL Net marginGWLL Gross profitGWLL Gross marginGWLL Operating incomeGWLL Operating marginGWLL Operating cash flowGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Total liabilitiesGWLL Shareholders’ equityGWLL overview →